Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Rethinking Patient And Site Engagement

Thu, 01/23/2020 - 5:50am

       

Executives On The Move: New Picks For Finance Posts At Cambrex And Editas Medicine, And Zimmer Biomet Fills Communications Spot

Thu, 01/23/2020 - 2:22am

Gene-editing company Editas Medicine appoints a new CFO, while Affimed and NexImmune bring new chief medical officers on board.

      Related Stories 

Amgen To Buy Out Japan JV With Astellas

Wed, 01/22/2020 - 9:52pm

Full, planned acquisition of Tokyo-based operation will give US biotech giant a firmer foothold in key market and new platform...

      Related Stories 

J&J’s Gorsky Hails Strong Performance By Immunology Therapies Tremfya, Stelara

Wed, 01/22/2020 - 12:54pm

A strong fourth quarter and full-year 2019 performance by J&J was driven by significant sales growth for Tremfya and Stelara...

      Related Stories 

Fewer US Market Access Restrictions For Branded I&I Drugs Will Drive Growth

Wed, 01/22/2020 - 11:46am

Access to branded drugs has remained steady, but there has been less management across brands by commercial payers, according to...

      Related Stories 

Finance Watch: Expect A Busy First Half For 2020 IPOs

Wed, 01/22/2020 - 10:32am

Public Company Edition: At the J.P. Morgan Healthcare Conference and Biotech Showcase it was noted that the US IPO market...

       

AstraZeneca Pledges To Become Carbon-Negative By 2030

Wed, 01/22/2020 - 7:43am

AstraZeneca has vowed to slash its carbon emissions to zero by 2025 and ensure its entire value chain is carbon...

      Related Stories 

Health Sector On High Alert As Wuhan Coronavirus Spreads

Tue, 01/21/2020 - 4:26pm

The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up...

      Related Stories 

Verrica Ready To Target Pediatric Dermatologists With First Molluscum Therapy

Tue, 01/21/2020 - 12:56pm

Anticipating a July approval of its cantharidin formulation, Verrica says it is poised to implement a buy-and-bill model for a...

      Related Stories 

AstraZeneca's Dobber On Ramping In Renal, Expanding In CV And Business Development

Tue, 01/21/2020 - 11:46am

Biopharmaceuticals President Ruud Dobber talked to Scrip about the launches of Lokelma and roxadustat in kidney disease, building with a...

      Related Stories 

Novartis MS Drug Mayzent Gets Europe OK

Tue, 01/21/2020 - 7:43am

Mayzent is the first oral treatment specifically indicated for patients with secondary-progressive multiple sclerosis and while it is expected to...

      Related Stories 

Pipeline Watch: Phase III Starts With EB-101, Tavapadon, Ziresovir

Tue, 01/21/2020 - 7:37am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...

      Related Stories 

Biopharma Leaders Join Trump And Thunberg In Davos

Tue, 01/21/2020 - 6:25am

Often dismissed as a meeting of the global elite, Davos is nevertheless a chance for biopharma leaders to take part...

      Related Stories 

Pages